Financials
- Market Capitalization 9.35 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 922 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.95 USD | +0.04% | +0.18% | +0.48% | +30.54% | 9.79 B USD | ||
| 937 | CORT Corcept Therapeutics Incorporated - Common Stock | 86.95 USD | -5.37% | -5.86% | +4.87% | +18.51% | 9.33 B USD | ||
| 968 | KYMR Kymera Therapeutics, Inc. - Common Stock | 110.24 USD | -7.63% | -4.83% | +33.58% | +86.53% | 9.07 B USD | ||
| 971 | HALO Halozyme Therapeutics, Inc. - Common Stock | 76.56 USD | +0.47% | -4.74% | +7.82% | +14.61% | 9.08 B USD |
Frequently asked questions about Ionis Pharmaceuticals, Inc. - Common Stock
What is the Ionis Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Ionis Pharmaceuticals, Inc. - Common Stock (IONS) is 56.59. Over the past 24 hours, the stock has changed by -2.85%. Follow the IONS chart for real-time price dynamics.
What is the stock ticker of Ionis Pharmaceuticals, Inc. - Common Stock?
Ionis Pharmaceuticals, Inc. - Common Stock trades under the ticker IONS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ionis Pharmaceuticals, Inc. - Common Stock stock going up?
IONS has changed by -32.55% over the last week, -23.34% over the last month, and -21.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ionis Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Ionis Pharmaceuticals, Inc. - Common Stock reported net income of -92.53 M for the last quarter. The previous quarter showed -229.39 M, which means net income changed by +59.66%.
How many employees does Ionis Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Ionis Pharmaceuticals, Inc. - Common Stock has 1 402 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ionis Pharmaceuticals, Inc. - Common Stock EBITDA?
Ionis Pharmaceuticals, Inc. - Common Stock EBITDA is -117.3 M, and its EBITDA margin is -47.67%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ionis Pharmaceuticals, Inc. - Common Stock stock?
You can buy Ionis Pharmaceuticals, Inc. - Common Stock (IONS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ionis Pharmaceuticals, Inc. - Common Stock stock?
Investing in Ionis Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IONS chart and related analysis on metatrader.com as part of your research.